Good to see another company on the ASX draw attention to Pancreatic cancer with asx ticker code ATX in Phase 2a trials with FDA Designation. . Interesting that Oncosil is actually commercially selling with improving sales , further expansion to come, awaiting approvals, in clinical trials and has been trading recently in a similar Market Cap range approximately around the $ 40 to $ 50 million range.
- Forums
- ASX - By Stock
- OSL
- Ann: Two more PANCOSIL Trial treatments using OncoSil device
Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-263
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $30.27M |
Open | High | Low | Value | Volume |
0.8¢ | 0.9¢ | 0.8¢ | $60.16K | 7.448M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 14420152 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 7652730 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
41 | 14420152 | 0.008 |
16 | 9467668 | 0.007 |
12 | 6172106 | 0.006 |
7 | 4000198 | 0.005 |
8 | 8512824 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 7652730 | 8 |
0.010 | 11686333 | 11 |
0.011 | 10592564 | 21 |
0.012 | 8485789 | 7 |
0.013 | 5349700 | 3 |
Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |